Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.190
-0.080 (-2.45%)
At close: Mar 12, 2026, 4:00 PM EDT
3.250
+0.060 (1.88%)
After-hours: Mar 12, 2026, 7:44 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $307.09 million as of March 12, 2026. Its market cap has increased by 217.31% in one year.
Market Cap
307.09M
Enterprise Value
172.94M
1-Year Change
217.31%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $307.09M, an increase of 30.38%. That is a compound annual growth rate of 4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 314.79M | 49.32% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 319.32M |
| Rezolute | 313.69M |
| Avalo Therapeutics | 309.35M |
| Adlai Nortye | 308.49M |
| Palisade Bio | 302.48M |
| Puma Biotechnology | 299.15M |
| AC Immune | 296.83M |
| Voyager Therapeutics | 290.25M |